Skip to content

Effect of remimazolam on peri-operative stress response and immune function

A comparative study of the effects of rimimazole and propofol on peri-operative stress response and immune function in patients undergoing radical gastrectomy under general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047957
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Propofol as the exclusive sedative
Group 2:Remimazolam as the exclusive sedative

Sponsors

Yixing People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent radical gastrectomy under general anesthesia in Yixing People's Hospital; 2. Aged 50-80 years; 3. ASA classification I-II; 4. No history of immune diseases; 5. No history of radiotherapy or chemotherapy; 6. No history of taking immunosuppressants; 7. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy to remazolam; 2. Recently taking benzodiazepines; 3. Serious postoperative complications; 4. Reoperation after operation; 5. Refuse to continue participating in the research.

Design outcomes

Secondary

MeasureTime frame
blood pressure;heart rate;recovery time;extubation time;oxygen saturation;blood gas analysis;pain numerical score;

Primary

MeasureTime frame
adrenocorticotropic hormone;cortisol;norepinephrine;IL-6;blood glucose;total lymphocytes;helper lymphocytes;cytotoxic lymphocytes;natural killer cells;

Countries

China

Contacts

Public ContactHan Chao

Yixing People's Hospital

staff940@yxph.com+86 13961568178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026